Feed Preview

Fast Growing

Membranoproliferative Glomerulonephritis

Membranoproliferative Glomerulonephritis diagram by Nephron, Wikimedia
Nephron, Wikimedia

Membranoproliferative glomerulonephritis is type of Chronic glomerulonephritis characterized histologically by proliferation of mesangial cells, increase in the mesangial extracellular matrix, and a thickening of the glomerular capillary walls. Discover the latest research on membranoproliferative glomerulonephritis here.

Top 20 most recent papers
Journal of the American Society of Nephrology : JASN

Large-Scale Whole-Genome Sequencing Reveals the Genetic Architecture of Primary Membranoproliferative GN and C3 Glomerulopathy

Journal of the American Society of Nephrology : JASNJanuary 11, 2020
Adam P LevineDaniel P Gale
Asian Journal of Transfusion Science

Role of de novo DQ donor-specific antibody in antibody-mediated rejection in renal transplant recipient: A case study

Asian Journal of Transfusion ScienceJanuary 4, 2020
Mohit ChowdhryVandana Sharma
Deutsche medizinische Wochenschrift

C3 glomerulopathy and MPGN - current classification

Deutsche medizinische WochenschriftFebruary 19, 2020
Bernd Hohenstein
Clinical Journal of the American Society of Nephrology : CJASN

Screening for Cancer in Patients with Glomerular Diseases

Clinical Journal of the American Society of Nephrology : CJASNFebruary 6, 2020
Emmanuelle Plaisier, Pierre Ronco
Arthritis Research & Therapy

ALW peptide ameliorates lupus nephritis in MRL/lpr mice

Arthritis Research & TherapyDecember 4, 2019
Huixia WangYumin Xia
KI Reports

Epidemiology and Pathophysiology of Glomerular C4d Staining in Native Kidney Biopsies

KI ReportsJanuary 1, 2020
Cinthia B DrachenbergMario F Rubin
Clinical Journal of the American Society of Nephrology : CJASN

Sensitivity and Specificity of Pathologic Findings to Diagnose Lupus Nephritis

Clinical Journal of the American Society of Nephrology : CJASNOctober 28, 2019
Satoru KudoseGlen S Markowitz
Journal of Inflammation

Mesangial cells are key contributors to the fibrotic damage seen in the lupus nephritis glomerulus

Journal of InflammationDecember 7, 2019
Rachael D WrightMichael W Beresford
Clinical and Molecular Hepatology

Extrahepatic manifestations of hepatitis E virus: An overview

Clinical and Molecular HepatologyOctober 12, 2019
Fotios S FousekisDimitrios K Christodoulou
Frontiers in Immunology

Complement Inhibitors in Clinical Trials for Glomerular Diseases

Frontiers in ImmunologyOctober 16, 2019
Peter F ZipfelChristine Skerka
BMC Nephrology

TAFRO syndrome as a cause of glomerular microangiopathy: a case report and literature review

BMC NephrologyOctober 19, 2019
Yoshikuni NagayamaKatsuyuki Matsui
Transactions of the American Clinical and Climatological Association


Transactions of the American Clinical and Climatological AssociationSeptember 14, 2019
George C Tsokos, Maria G Tsokos

See more papers from this feed

Related Feeds

Acute Disseminated Encephalomyelitis

Acute disseminated encephalomyelitis (ADEM) is a rare inflammatory demyelinating disease of the central nervous system. Discover the latest research on acute disseminated encephalomyelitis here.

Addison Disease

Addison's disease, also known as primary adrenal insufficiency and hypocortisolism, is a long-term endocrine disorder in which the adrenal glands do not produce enough steroid hormones. Discover the latest research on Addison's disease here.

Adult-Onset Still's Disease

Adult-onset Still's disease (AOSD) is a form of Still's disease, a rare systemic autoinflammatory disease characterized by the classic triad of persistent high spiking fevers, joint pain, and a distinctive salmon-colored bumpy rash. Discover the latest research on AOSD here.

Anti-N-Methyl-D-Aspartate Receptor Encephalitis

Anti-N-Methyl-D-Aspartate (NMDA) receptor encephalitis is a form of of brain inflammation due to antibodies against NMDA receptors. Discover the latest research on anti-NMDA receptor encephalitis here.

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Autoimmune Disease Therapy

In autoimmune diseases, the immune system responds and attacks self-antigens and damages or impairs the function of the tissues. The treatment for autoimmune diseases often involves immunosuppressive agents, but newer treatments are being investigated. Discover the latest research on autoimmune disease therapy here.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Autoimmune Hemolytic Anemia

Autoimmune hemolytic anemia (AIHA) occurs when antibodies directed against the person's own red blood cells (RBCs) cause them to burst (lyse), leading to an insufficient number of oxygen-carrying red blood cells in the circulation. Discover the latest research on AIHA here.

Autoimmune Hepatitis

Autoimmune hepatitis formerly called lupoid hepatitis, is a chronic, autoimmune disease of the liver that occurs when the body's immune system attacks liver cells causing the liver to be inflamed. Discover the latest research on autoimmune hepatitis here.

© 2020 Meta ULC. All rights reserved